Arrowhead Research | Capitale Ordinario

Ordinary Share Capital Cambiamento Data
Agios Pharmaceuticals USD 72K 0 2023-12
Alnylam Pharmaceuticals USD 1.26M 4K 2023-12
Arrowhead Research USD 200K 0 2023-12
Incyte USD 224K 0 2023-12
Ionis Pharmaceuticals USD 144K 1000 2023-12
Ligand Pharmaceuticals USD 18K 0 2023-12
Merck USD 1.79B 0 2023-09
Moderna USD 38.2K 100 2023-12
Sarepta Therapeutics USD 9K 0 2023-09
TG Therapeutics USD 151K 0 2023-09
Ultragenyx Pharmaceutical USD 72K 1000 2023-09
Vertex Pharmaceuticals USD 2.6M 0 2023-09
Xencor USD 611K 4K 2023-12



Arrowhead Research Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.